APA (7th ed.) Citation

Nakajima, A., Yamanaka, T., Honda, Y., Imajo, K., Taguri, M., Yoneda, M., . . . Saito, S. Comparing the effects of tofogliflozin and pioglitazone in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus (ToPiND study): A randomized prospective open-label controlled trial. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Nakajima, Atsushi, et al. Comparing the Effects of Tofogliflozin and Pioglitazone in Non-alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus (ToPiND Study): A Randomized Prospective Open-label Controlled Trial. BMJ Publishing Group.

MLA (9th ed.) Citation

Nakajima, Atsushi, et al. Comparing the Effects of Tofogliflozin and Pioglitazone in Non-alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus (ToPiND Study): A Randomized Prospective Open-label Controlled Trial. BMJ Publishing Group.